Druckenmiller Adds Healthcare Stocks to Portfolio

Author's Avatar
Dec 15, 2014

Pittsburgh native Stanley Druckenmiller (Trades, Portfolio) is said to be worth more than $3 billion. He was chairman and president of Duquesne Capital, which he founded in 1981, until he closed it in 2010 because he did not believe he could continue to deliver high returns to his clients.

Still, he has done all right for himself. He has a fondness for healthcare holdings that could be easily seen in his third-quarter transactions.

Druckenmiller added 24 companies to his portfolio in the third quarter – Gilead Sciences Inc (GILD, Financial), Amgen Inc (AMGN, Financial), Home Depot Inc (HD, Financial), Costco Wholesale Corp (COST, Financial), Kohl's Corp (KSS, Financial), Merck & Co Inc (MRK, Financial), Target Corp (TGT, Financial), Lowe's Companies Inc (LOW, Financial), Mellanox Technologies Ltd (MLNX, Financial), Vertex Pharmaceuticals Inc (VRTX, Financial), American Eagle Outfitters (AEO, Financial), Macy's Inc (M, Financial), Williams-Sonoma Inc (WSM), Charles Schwab Corp (SCHW), HDFC Bank Ltd (HDB), YPF Sociedad Anonima (YPF), Foot Locker Inc (FL), SPDR Dow Jones Industrial Average ETF (DIA), Nordstrom Inc (JWN), L Brands Inc (LB), ARIAD Pharmaceuticals Inc (ARIA), NewLink Genetics Corp (NLNK), Kite Pharma Inc (KITE) and Alibaba Group Holding Ltd (BABA).

Druckenmiller purchased 217,500 shares of Gilead, a California-based biotechnology company, for an average price of $97.92 per share. The deal had a 2.8% impact on his portfolio.

03May20171231541493832714.png

He also purchased 158,900 shares of Amgen, a California-based pharmaceutical company, for an average price of $130.56 per share. The transaction had a 2.7% impact on his portfolio.

03May20171231541493832714.png

The purchase of 222,400 shares of Home Depot, a Georgia-based home improvement retailer, for an average price of $85.77 per share had a 2.5% impact on his portfolio.

03May20171231541493832714.png

Druckenmiller’s purchases of stock in Costco, Kohl’s, Merck and Target each had a 2.4% impact on his portfolio.

Druckenmiller added to existing stakes in two companies – Celgene Corp (CELG) and McDermott International Inc (MDR).

The purchase of 284,600 shares of Celgene, a New Jersey-based biotechnological company, for an average price of $90.26 per share had an impact of 3.3% on his portfolio.

03May20171231551493832715.png

Druckenmiller acquired 1,255,000 shares of McDermott International, a Houston-based oil and gas company, for an average price of $7.21 per share. The transaction had a 0.88% impact on his portfolio.GOOG,

03May20171231551493832715.png

Divestitures and reductions

Druckenmiller sold his stakes in 29 companies – Google Inc (GOOG), Facebook Inc (FB), Teva Pharmaceutical Industries Ltd (TEVA), SanDisk Corp (SNDK), EOG Resources Inc (EOG), Range Resources Corp (RRC), Halliburton Co (HAL), DISH Network Corp (DISH), Petroleo Brasileiro SA Petrobras (PBR), Baidu Inc (BIDU), Phillips 66 (PSX), Pioneer Natural Resources Co (PXD), Allegheny Technologies Inc (ATI), NXP Semiconductors NV (NXPI), EQT Corp (EQT), Devon Energy Corp (DVN), Canadian Pacific Railway Ltd (CP), Lennar Corp (LEN), AstraZeneca PLC (AZN), FluoAALr Corp (FLR), DR Horton Inc (DHI), HCA Holdings Inc (HCA), Occidental Petroleum Corp (OXY), Humana Inc (HUM), American Airlines Group Inc (AAL), SunPower Corp (SPWR), Valero Energy Corp (VLO), Marathon Petroleum Corp (MPC) and Expeditors International of Washington Inc (EXPD).

Druckenmiller reduced his holdings in four companies – Market Vectors Etf Trust (GDX), Google Inc (GOOGL), Walgreen Co (WAG) and Alcoa Inc (AA).

To view the portfolios of more gurus, visit the List of Gurus page. Not a premium member of GuruFocus? Try it free for 7 days.